Go Pro

CNS Pharmaceuticals (CNSP) News Today

CNS Pharmaceuticals logo
$5.68 +0.16 (+2.90%)
As of 11:15 AM Eastern
This is a fair market value price provided by Massive. Learn more.

CNS Pharmaceuticals Latest News

Why did CNSP stock surge 330% today?
CNS Pharmaceuticals Inc.
CNS Pharmaceuticals (CNSP) Receives a Buy from Maxim Group
CNS Pharmaceuticals Appoints New Chief Medical Officer
CNS Pharmaceuticals stock falls after CEO steps down
CNS Pharmaceuticals files to sell 5.22M shares of common stock, warrants
CNS Pharmaceuticals sees cash runway into 1Q26
CNS Pharmaceuticals announces primary analysis of berubicin in GBM

CNS Pharmaceuticals Media Mentions By Week

CNS Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CNSP
News Sentiment

0.93

0.98

Average
Healthcare
News Sentiment

CNS Pharmaceuticals News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CNSP Articles
This Week

1

1

CNSP Articles
Average Week

CNS Pharmaceuticals Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
3
+200%
Page Views
1,033
+20%
Get CNS Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNSP and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for CNS Pharmaceuticals dated 8/12/2026.
From Our Partners